Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Allergy and Immunology

Derm Allergy/Immunology

Association of atopic dermatitis severity with learning disability in children

JAMA | Jun 22, 2021 Derm Allergy/Immunology

Association of immunosuppressants with mortality of patients with bullous pemphigoid: A nationwide population-based cohort study

Dermatology | Jun 22, 2021 Derm Allergy/Immunology

Association between atopic dermatitis and educational attainment in Denmark

JAMA Dermatology | Jun 21, 2021 Derm Allergy/Immunology

Alopecia areata severity index (AASI): A reliable scoring system to assess the severity of alopecia areata on face and scalp- A pilot study

Journal of Cosmetic Dermatology | Jun 20, 2021 Derm Allergy/Immunology

Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double-blinded placebo-controlled interventional study

Journal of Cosmetic Dermatology | Jun 18, 2021 Derm Allergy/Immunology

Dupilumab treatment in patients with atopic dermatitis: A comparative cohort study between the Netherlands and Japan shows a discrepancy in patient-reported outcome measures

British Journal of Dermatology | Jun 15, 2021 Derm Allergy/Immunology

Prevalence and early-life risk factors of school-age allergic multimorbidity: The EuroPrevall-iFAAM birth cohort

Allergy | Jun 12, 2021 Derm Allergy/Immunology

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial

Journal of the European Academy of Dermatology and Venereology | Jun 09, 2021 Derm Allergy/Immunology

Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study

Journal of the American Academy of Dermatology | Jun 07, 2021 Derm Allergy/Immunology

Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa

Cytokine | May 30, 2021 Derm Allergy/Immunology

« Prev 1 … 5 6 7 8 9 … 43 Next »

Association of atopic dermatitis severity with learning disability in children

Association of immunosuppressants with mortality of patients with bullous pemphigoid: A nationwide population-based cohort study

Association between atopic dermatitis and educational attainment in Denmark

Alopecia areata severity index (AASI): A reliable scoring system to assess the severity of alopecia areata on face and scalp- A pilot study

Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double-blinded placebo-controlled interventional study

Dupilumab treatment in patients with atopic dermatitis: A comparative cohort study between the Netherlands and Japan shows a discrepancy in patient-reported outcome measures

Prevalence and early-life risk factors of school-age allergic multimorbidity: The EuroPrevall-iFAAM birth cohort

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial

Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study

Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Association of atopic dermatitis severity with learning disability in children

Association of immunosuppressants with mortality of patients with bullous pemphigoid: A nationwide population-based cohort study

Association between atopic dermatitis and educational attainment in Denmark

Alopecia areata severity index (AASI): A reliable scoring system to assess the severity of alopecia areata on face and scalp- A pilot study

Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double-blinded placebo-controlled interventional study

Dupilumab treatment in patients with atopic dermatitis: A comparative cohort study between the Netherlands and Japan shows a discrepancy in patient-reported outcome measures

Prevalence and early-life risk factors of school-age allergic multimorbidity: The EuroPrevall-iFAAM birth cohort

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial

Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study

Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Select Specialty

Select Topic